For The Better

Researchers examined mortality rates and federal and state election data for all counties in the U.S. from 2001 to 2019. The team found what they call a ‘mortality gap’ — a widening difference between age-adjusted death rates in counties that had vote…

A new molecule synthesized by a University of Texas at Dallas researcher kills a broad spectrum of hard-to-treat cancers, including triple-negative breast cancer, by exploiting a weakness in cells not previously targeted by other drugs.

Researchers examining the brain at a single-neuron level found that computation happens not just in the interaction between neurons, but within each individual neuron. Each of these cells, it turns out, is not a simple switch, but a complicated calcula…

A pioneering study has shed new light on how subcellular organelles divide and multiply.

An inhaled immunotherapy successfully treated cancer in some companion dogs as part of a clinical trial conducted by oncology and veterinary researchers. Results show potential for fighting cancer in humans as well.

A drug currently used in just 1% of cancers has significant potential against the remaining 99%, according to a new study. Ivosidenib, or AG-120, is currently used against cancers that have a mutation in the IDH1 gene. However, study results show that …